At an event last week, Evolve Houston celebrated its relaunch, a new leader, and its microgrant program. Photo courtesy of Evolve

A Houston organization focused on promoting electromobility in Houston has announced some big updates.

Evolve Houston, founded in 2019 through Houston's Climate Action Plan, has relaunched as of its event Thursday, August 18. The nonprofit has also named Casey Brown as the new president and executive director. Formerly at Halliburton and Coretrax, Brown's appointment went into effect this month.

"I am honored to have been appointed by the board to lead Evolve into the next phase of our electric vehicle journey," says Brown. "I look forward to working with our partners to get more electric cars, buses, and bikes on the road, and to publish Evolve's electrification roadmap 2.0 early next year."

Additionally, thanks to funding from Evolve Corporate Catalysts General Motors and bp, the organization has introduced the eMobility Microgrant Initiative, which will facilitate a peer-review process to award microgrants to local electromobility projects. Applications for the grants are now open online and will be accepted through September 16 at 6 pm.

"Evolve Houston is committed to supporting a just transition to a more sustainable transportation system, so all residents can receive the benefits of eMobility," says Grace Millsap, Evolve Houston director of equity and investment, in a news release. "The Greater Houston area has made significant progress in improving livability. We must continue and bring the eMobility revolution to Houston's communities that remain disproportionately in need of a cleaner environment, better services, and diversified economic development.

"Evolve's eMobility Microgrant Initiative will empower and elevate residents' voices, drive further community investment, and prioritize the communities who are most impacted by climate and mobility challenges," she continues.

A community-focused initiative, the Equity Program has been established to address poor air quality and limited access to public transportation in vulnerable communities, per the release. This fall, Evolve will invest the microgrants into community-led efforts that are increasing access to all forms of electric mobility and EV charging stations.

"The Complete Communities Initiative bridges the gap between equity and opportunity for our city's most under-resourced and underserved neighborhoods. Residents living in the Complete Communities have made it clear that its past time to address the transportation and climate change challenges that impact their quality of life," says Shannon Buggs, director of the Mayor's Office for Complete Communities, in the release.

"Increasing chronic air pollution and lack of equitable mobility has disproportionately affected low-to-moderate income neighborhoods," she continues. "With the help of community leaders, the Evolve Houston Equity Program provides a pathway for our City to ensure that every resident lives in a healthy, sustainable and thriving community."

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

European spacecraft developer expands to Houston with U.S. business, new lab

houston hq

European aerospace manufacturer The Exploration Company has established its first U.S. entity and named Space City as its headquarters.

The company announced earlier this month that it has launched TEC Federal to support U.S. government customers and agencies, and to scale The Exploration Company's engineering operations in the country.

Mark Kirasich serves as president of TEC Federal. Kirasich most recently served as the senior director of human spaceflight at Blue Origin after a nearly 40-year career at NASA.

The Exploration Company is developing the reusable Nyx space vehicle. Nyx is designed to take off from any heavy launcher in the world. It will then dock at space stations, retrieve up to 3,000 kilograms of cargo, splash down and return the cargo to Earth. The company aims to make Nyx fully reusable for up to 10 missions, making it a more affordable and sustainable option for aerospace missions.

The Exploration Company completed a successful drop test of the spacecraft in May in the Mojave Desert. The company says Nyx is slated to perform its first flight demonstration in 2028.

In addition to launching the Houston business, The Exploration Company also opened its new Rapid Innovation Lab near Houston's NASA Johnson Space Center on Space Park Drive.

The Exploration Company opened its Rapid Innovation Lab earlier this month. Photo via LinkedIn

The Rapid Innovation Lab features a full-scale mockup of the future Nyx crew capsule as well as ongoing development and testing of the Nyx cargo capsule, according to the company.

The Exploration Company says the new lab will allow its engineers, designers, and operators to prototype and test crew interfaces. It will also support partnerships with NASA personnel and astronauts.

“Houston gives us direct access to the people and expertise that have built and operated human spaceflight systems for decades. We’re excited to invest and expand around that— engineers, operators, and astronauts working together and moving quickly towards building a crew capsule.” Hélène Huby, founder and CEO of The Exploration Company, said in a blog post.

According to The Houston Chronicle, The Exploration Company has about 30 employees in the Houston area.

The company was founded in 2021 by Huby, a French rocket scientist, and has raised more than $350 million in venture capital. It operates out of Germany, France, Luxembourg, Spain and Italy, with offices in the U.S. and the United Arab Emirates. It is also developing a reusable, high-thrust rocket engine known as Storm.

UH lands $4M NIH grant to study early signs of autoimmune disease

NIH funding

The University of Houston recently received a $4 million National Institutes of Health grant to support a 10-year longitudinal study to identify the earliest biological markers of autoimmune disease.

Led by Chandra Mohan, the Hugh Roy and Lillie Cranz Cullen Endowed Professor of Biomedical Engineering, the study aims to examine what causes Systemic Autoimmune Rheumatic Diseases (SARDs) and to identify targets for future treatments. The study will be carried out in collaboration with Dr. Karen Costenbader at Harvard Medical School, Boston.

SARDs include conditions like rheumatoid arthritis, systemic lupus erythematosus, Sjögren’s syndrome and systemic sclerosis—all are considered chronic diseases currently without a cure. Autoimmune diseases affect over 30 million people globally, according to UH.

SARDs occur when the body’s immune system attacks healthy, non-threatening tissues and organs. According to UH, in these diseases, the body often attacks nuclear antigens, creating anti-nuclear autoantibodies, which can be early detection signs for SARDs in more than 50 percent of patients, Mohan says.

Researchers will study blood samples and environmental exposure over the 10 years to better understand anti-nuclear autoantibodies.

“Collectively, these studies will help identify the genetic, environmental and cellular factors that are operative at the two steps of SARD development, namely the emergence of anti-nuclear autoantibodies and disease onset,” Mohan said in a news release. “ More importantly, these studies will highlight functional molecular pathways and mechanisms that may be operative at each step."

Mohan predicts that looking at SARDs’ shared characteristics, rather than each disease individually, could help identify more treatment methods.

“Individual SARDs have been examined in silos without an attempt to discern shared underlying features at the molecular level,” he added in the release. “Current understanding of the initial (and likely shared) origins of SARDs is only rudimentary but urgently needed to develop means for prevention and treatment.”

Earlier this year, UH also received an $11 million NIH grant to conduct a first-of-its-kind study of early language development in children ages 18 to 24 months. Read more here.